Qube Research & Technologies (QRT)
CAH icon

Qube Research & Technologies (QRT)’s Cardinal Health CAH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.8M Sell
108,557
-903,752
-89% -$188M 0.02% 798
2026
Q1 		$214M Sell
1,012,309
-34,826
-3% -$7.5M 0.24% 85
2025
Q4 		$215M Sell
1,047,135
-326,948
-24% -$61.5M 0.22% 85
2025
Q3 		$216M Sell
1,374,083
-45,867
-3% -$7.09M 0.22% 90
2025
Q2 		$239M Buy
1,419,950
+130,730
+10% +$19.4M 0.24% 74
2025
Q1 		$178M Buy
1,289,220
+115,879
+10% +$14.8M 0.21% 111
2024
Q4 		$139M Sell
1,173,341
-127,199
-10% -$14.9M 0.18% 133
2024
Q3 		$144M Sell
1,300,540
-352,606
-21% -$36.9M 0.21% 91
2024
Q2 		$163M Buy
1,653,146
+386,682
+31% +$39.4M 0.26% 77
2024
Q1 		$142M Sell
1,266,464
-65,953
-5% -$7.12M 0.22% 102
2023
Q4 		$134M Buy
1,332,417
+440,084
+49% +$43.7M 0.26% 81
2023
Q3 		$77.5M Buy
892,333
+796,899
+835% +$72M 0.2% 122
2023
Q2 		$9.03M Buy
95,434
+4,811
+5% +$406K 0.03% 561
2023
Q1 		$6.84M Sell
90,623
-18,022
-17% -$1.36M 0.03% 581
2022
Q4 		$8.35M Buy
+108,645
New +$8.26M 0.04% 531
2021
Q2 		– Sell
-4,266
Closed -$259K – 2300
2021
Q1 		$259K Sell
4,266
-47,951
-92% -$2.65M ﹤0.01% 1528
2020
Q4 		$2.8M Buy
+52,217
New +$2.71M 0.04% 486
2020
Q3 		– Sell
-205,100
Closed -$10.7M – 1708
2020
Q2 		$10.7M Buy
+205,100
New +$10.6M 0.16% 147
2020
Q1 		– Sell
-42,870
Closed -$2.17M – 1167
2019
Q4 		$2.17M Buy
+42,870
New +$2.21M 0.07% 339
2018
Q4 		– Sell
-574
Closed -$31K – 378
2018
Q3 		$31K Sell
574
-2,795
-83% -$143K ﹤0.01% 927
2018
Q2 		$165K Buy
+3,369
New +$191K 0.1% 194

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Qube Research & Technologies (QRT)'s CAH Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Cardinal Health (CAH) stake by 89% in Q2 2026, selling an estimated $188M and leaving 108,557 shares worth $25.8M. The position accounts for 0.02% of the portfolio, ranked #798.

Qube Research & Technologies (QRT) first reported a position in CAH in Q2 2018 and has held it in 21 quarters since. The position peaked at $239M in Q2 2025. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Qube Research & Technologies (QRT) held 108,557 shares of Cardinal Health worth $25.8M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 903,752 Cardinal Health shares in Q2 2026, an estimated $188M.
  • Cardinal Health made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #798 holding.
  • Qube Research & Technologies (QRT) first reported a position in Cardinal Health in Q2 2018 and has held it in 21 quarters since.
  • Qube Research & Technologies (QRT)'s Cardinal Health position peaked at $239M in Q2 2025.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.